Article Text

Download PDFPDF
A meningeal myofibroblastic neoplasm related to solitary fibrous tumour and associated with a malignant neuroblastic element
  1. T S Bracey1,
  2. D A Hilton1,
  3. T Sulkin2,
  4. M E F Smith1
  1. 1Department of Histopathology, Derriford Hospital, Plymouth, Devon, UK
  2. 2Department of Radiology, Royal Cornwall Hospital, Truro, Cornwall, UK
  1. Correspondence to Dr M E F Smith, Department of Histopathology, Derriford Hospital, Plymouth TR1 3LJ, Devon, UK; mark.smith{at}phnt.swest.nhs.uk

Abstract

Background Solitary fibrous tumour (SFT) is a rare mesenchymal tumour now described at many locations, including the meninges. Intracranial SFT closely resembles meningioma clinically and radiologically, and, like meningioma, reports of meningeal SFT suggest a relatively benign behaviour after complete resection. Histopathological features distinguishing SFT from meningioma include variable cellularity, spindle cells arranged in fascicles, staghorn blood vessels and immunopositivity for CD34.

Clinical presentation The case is reported of a 60-year-old man with an anterior cranial fossa meningeal-based mass, which was resected. Histology showed some features in common with SFT (variable cellularity, spindled morphology, CD34 expression), but included an epithelioid element with cytokeratin and desmin immunopositivity, and lacked the characteristic vascular pattern of SFT. Histological features of meningioma were lacking. Recurrence of the tumour with extracranial extension 9 years later resulted in death of the patient. Histological examination revealed similar biphasic epithelioid and spindled CD34-immunopositive appearance to the earlier tumour, but in addition showed a high-grade element resembling olfactory neuroblastoma.

Conclusion This case report is of a meningeal-based mesenchymal neoplasm with histological similarities to SFT. Its morphology and immunophenotype, however, are distinct from SFT and hence it is proposed that it is a newly described entity. In addition, recurrence of the tumour with a high-grade neuroblastic element has, to our knowledge, not previously been described in SFT.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Competing interests None.

  • Patient consent Obtained from patient's relative.

  • Provenance and peer review Not commissioned; externally peer reviewed.